Complete mitochondrial genome sequencing and phylogenetic analysis of Phellinus igniarius [PDF]
Scientific ReportsThe mitochondrial whole genome of Phellinus igniarius was sequenced with the objective of examining the evolutionary relationships amongst related species. The entire mitochondrial genome was assembled using Illumina sequencing technology. The structural
Qingxu He +5 more
doaj +4 more sources
Neuraminidase Inhibitors from the Fruiting Body of Phellinus igniarius [PDF]
Mycobiology, 2016 During our ongoing investigation of neuraminidase inhibitors from medicinal fungi, we found that the fruiting bodies of Phellinus igniarius exhibited significant inhibitory activity against neuraminidase from recombinant H3N2 influenza viruses. Two active compounds were isolated from the methanolic extract of P.
Bong Sik Yun, Byung Soon Hwang
exaly +5 more sources
Simultaneous Quantification of Antioxidant Compounds in Phellinus igniarius Using Ultra Performance Liquid Chromatography-Photodiode Array Detection-Electrospray Ionization Tandem Mass Spectrometry. [PDF]
PLoS ONE, 2016 Natural antioxidants are widely used in the life sciences. Phellinus igniarius is a historically used natural antioxidant containing a variety of active compounds. Phenols, particularly Inoscavin A and Hypholomine B, are found in the high concentrations.
Dan Shou +5 more
doaj +2 more sources
: A Pharmacologically Active Polypore Mushroom
Natural Product Communications, 2016 Mushrooms have been widely used in traditional medicine for the treatment of various diseases. Today, their therapeutic value is scientifically studied and appreciated. Research indicates that polypores - a large group of fungi of the phylum Basdiomycota
Ewa Zapora +3 more
doaj +3 more sources
Protective effects of polysaccharide SH-P-1-1 isolated from Phellinus igniarius on hyperuricemia and gout via intestinal microecosystem regulation [PDF]
Frontiers in NutritionIntroductionAlthough Phellinus igniarius has been shown to treat hyperuricemia (HUA) and gout, a self-inflammatory disease caused by purine metabolism disorders, the underlying mechanisms remain unclear. Polysaccharides are among the main components of P.
Yanan Wang +14 more
doaj +2 more sources
The aqueous extract of Phellinus igniarius (SH) ameliorates dextran sodium sulfate-induced colitis in C57BL/6 mice. [PDF]
PLoS ONE, 2018 Phellinus igniarius, which is called Sanghuang in Chinese, is a fungal herb widely used in Traditional Chinese Medicine to treat stomachache, inflammation and tumors.
Yuqing Sun +7 more
doaj +2 more sources
Polyphenol extract from Phellinus igniarius protects against acrolein toxicity in vitro and provides protection in a mouse stroke model. [PDF]
PLoS ONE, 2015 The basidiomycetous mushroom Phellinus igniarius (L.) Quel. has been used as traditional medicine in various Asian countries for many years. Although many reports exist on its anti-oxidative and anti-inflammatory activities and therapeutic effects ...
Papawee Suabjakyong +6 more
doaj +2 more sources
Optimization of Extraction of Total Terpenoids from Phellinus igniarius Using Response Surface Methodology and Evaluation of Their Antioxidant Activity [PDF]
MoleculesPhellinus igniarius is a medicinal fungus rich in terpenoids with potential biological activities. In this study, the P. igniarius terpenoid-enriched extract (PITT) was optimized using single-factor experiments combined with response surface methodology ...
Lulu Li +8 more
doaj +2 more sources
Water-Soluble Intracellular Polysaccharides (IPSW-2 to 4) from Phellinus igniarius Mycelia: Fractionation, Structural Elucidation, and Antioxidant Activity [PDF]
FoodsPhellinus igniarius is a medicinal fungus. Nonetheless, research on its water-soluble intracellular polysaccharides (IPSW-2 to 4) fractionation, structural elucidation, and antioxidant activity is limited.
Isaac Duah Boateng, Xiaoming Yang
doaj +2 more sources
Food FrontiersNonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide and is characterized by excessive hepatic fat accumulation that can progress to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma. Currently,
Ying‐Jun Zhang +8 more
doaj +2 more sources